No Photo Available

Last Update

2016-11-22T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Scott Pearsall?

Scott Pearsall

Senior Director

ACCELERON PHARMA INC

Direct Phone: (617) ***-****       

Email: s***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

ACCELERON PHARMA INC

128 Sydney Street

Cambridge, Massachusetts 02139

United States

Company Description

Acceleron is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to treat serious and rare diseases. Its pioneering research platform leverages the powerful biology behind the b ... more

Find other employees at this company (165)

Background Information

Education

Ph.D

Web References (13 Total References)


Data presented on September 17, 2006 ...

www.newsrx.com [cached]

Data presented on September 17, 2006 by Scott Pearsall, PhD, director of Preclinical Pharmacology at Acceleron, generated in a mouse model of osteoporosis that showed ACE-011 has positive effects on trabecular and cortical bone, increased bone mineral density and bone strength.


BIO.COM: Biotechnology Pharmaceutical Market, Stocks, Finance, Merger, Acquisition - Biotech, Pharma, Biomedical

www.bio.com [cached]

Data presented on September 17, 2006 by Scott Pearsall, Ph.D., Director of Preclinical Pharmacology at Acceleron, generated in a mouse model of osteoporosis that showed ACE-011 has positive effects on trabecular and cortical bone, increased bone mineral density and bone strength.


Acceleron Pharma

www.acceleronpharma.com [cached]

Data presented on September 17, 2006 by Scott Pearsall, Ph.D., Director of Preclinical Pharmacology at Acceleron, generated in a mouse model of osteoporosis that showed ACE-011 has positive effects on trabecular and cortical bone, increased bone mineral density and bone strength.


Acceleron Pharma Presents ACE-011 Preclinical Data Demonstrating Both Anabolic and Anti-Resorptive Properties

www.acceleronpharma.com [cached]

Data presented on September 17, 2006 by Scott Pearsall, Ph.D., Director of Preclinical Pharmacology at Acceleron, generated in a mouse model of osteoporosis that showed ACE-011 has positive effects on trabecular and cortical bone, increased bone mineral density and bone strength.


Acceleron Pharma ยป Acceleron Pharma Presents ACE-011 Preclinical Data Demonstrating Both Anabolic and Anti-Resorptive Properties

www.acceleronpharma.com [cached]

Data presented on September 17, 2006 by Scott Pearsall, Ph.D., Director of Preclinical Pharmacology at Acceleron, generated in a mouse model of osteoporosis that showed ACE-011 has positive effects on trabecular and cortical bone, increased bone mineral density and bone strength.

Similar Profiles

Other People with this Name

Other people with the name Pearsall

Janet Pearsall
SCO Family

Lee Pearsall
Greenville Consolidated School

Christian Pearsall
Office

Hilary Pearsall
Camden Coalition of Healthcare Providers

Christina Pearsall
Schell Bray Aycock Abel & Livingston PLLC

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory